• Mr Jorge will be taking over from Darren Flew, who has served as interim CEO since April 2021 and took over from former CEO Jonathan Hicks
• He is a highly credentialed senior executive with 25 years of global expereince in the food and beverage industry, particularly the dairy sector
• Mr Jorge began his career in 1997 when he joined Nestlé in Brazil and has most recently been Chief Operating Officer of Bubs Australia
• Beston is steady on the market with shares trading at 7.2 cents each

Beston Global Food (BFC) has appointed Fabrizio Jorge as CEO, effective April 1, 2022.

Mr Jorge will be taking over from Darren Flew, who has served as interim CEO since April 15, 2021, and replaced former CEO Jonathan Hicks who took three months compassionate leave due to family health reasons.

Mr Jorge is a highly credentialed senior executive with 25 years of global experience in the food and beverage industry, particularly in the dairy sector, across Australia, New Zealand, Europe, Africa, Latin America, Asia and the Middle East.

He was born in Brazil, is of Italian descent and is fluent in five languages.

From 2016 to 2018, Mr Jorge served as a Board Member of the Australian Dairy Industry Council and the Australian Dairy Products Federation.

He began his career in 1997 when he joined Nestlé in Brazil, and worked with the company across multiple executive positions in Asia, Africa, the Middle East and Oceania.

Since May 2021, Mr Jorge has been the Chief Operating Officer of Bubs Australia (BUB), where he oversaw significant growth into new markets in Asia and the US.

Mr Jorge commented on his appointment and said he is excited to be joining the company.

“Beston has built a solid core business in a growing and dynamic sector. I am excited about the future of the company and look forward to working with the board and the management team as we focus on driving investment returns for our shareholders,” Mr Jorge said.

“With a leading product portfolio, and a continuing focus on product innovation in protein products and protein derivatives, the group is well-positioned for its next stage of growth and profitability.”